Through our telehealth-based platform, we provide access to clinical expertise and personalized treatment plans without the need for in-person visits
Thats kind of like getting an A on one test in a class and calling it your GPA
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) mimic this hormone to slow gastric emptying, reducing appetite and curbing food cravings
The GLP-1 consumer over-indexes on food and beverage at about 9% higher than the non-user. Circana data shows 5.3% of consumers are actively embracing GLP-1s, and the number may rise to double-digits for those who have at least tried the drug, according to Lyons Wyatt
By targeting combined hormone pathways, they unlock potential benefits not found in Ozempic, paving the way toward a healthier you
In the SURMOUNT-1 trial at the highest dose, lean mass decreased by 5.67 kg or 10.9% from baseline, with only 25.7% of total weight lost coming from lean mass